These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6835564)

  • 21. [Fosfomycin in a hematology department].
    Dinelli CA; Montrasio PL; Tansini G
    Minerva Med; 1978 Dec; 69(59):4111-4. PubMed ID: 740308
    [No Abstract]   [Full Text] [Related]  

  • 22. [Improvement of the therapeutic efficacy of fosfomycin by addition of glucose-6-phosphate in the treatment of intraperitoneally infected mice (author's transl)].
    Hirschl A; Stanek G; Rotter M
    Zentralbl Bakteriol A; 1980; 246(4):562-6. PubMed ID: 6999793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency].
    Bär W; Grosch H; Ahland R; Krülls-Münch J
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1818-9. PubMed ID: 16052445
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment].
    Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO
    G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of phosphonomycin in experimental animals.
    Borowski J; Borowski E; Bobrowski M; Dzier-Zanowska D; Jakoniuk P; Zaremba M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1977; 22():3-9. PubMed ID: 100861
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of surgical infections with fosfomycin].
    Germiniani R; Colombo F; Lavorato F
    G Ital Chemioter; 1978; 25(2):115-22. PubMed ID: 755790
    [No Abstract]   [Full Text] [Related]  

  • 28. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and abuse of antibiotics in periodontal therapy.
    Ciancio S
    Dent Econ; 1993 Jun; 83(6):98-100. PubMed ID: 8243788
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical use of a new antibiotic molecule "fosfomycin" in ambulatory dental practice].
    Calura G; Bulgarelli L
    Minerva Stomatol; 1983; 32(2):267-70. PubMed ID: 6575245
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fosfomycin: analysis of the antibiotic and its effects in odontostomatologic diseases].
    Palattella G; Massi C; Corbelli V; Palattella E; Pignatelli N
    Clin Ter; 1985 May; 113(3):211-4. PubMed ID: 4017500
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fosfomycin for infections in the orodental area--clinical studies].
    Iizuka T; Iida M; Iwatsubo R; Ota Y; Kimura S
    Shikai Tenbo; 1984 Dec; 64(6):1221-5. PubMed ID: 6597618
    [No Abstract]   [Full Text] [Related]  

  • 33. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fosfomycin, a new antibiotic for wound infections].
    Henneking K; Schultheis KH
    Med Klin Prax; 1982 Jun; 77(13):44-8. PubMed ID: 7110028
    [No Abstract]   [Full Text] [Related]  

  • 35. Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
    Gisbert JP; Bermejo MF; Infante JM; Gallardo BP; Bermejo AB; Rodríguez JM; Andrés PR; García GG
    J Clin Gastroenterol; 2009 Apr; 43(4):384-5. PubMed ID: 19020466
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimicrobial potentiality of a new beta-lactum antibiotic fosfomycin.
    Dastidar SG; Mazumdar A; Mookerjee M; Chakrabarty AN
    Indian J Exp Biol; 1997 Mar; 35(3):300-1. PubMed ID: 9332178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of 2 antibiotic combinations in the treatment of rapidly progressing periodontitis].
    Kone D; Kamagate A
    Odontostomatol Trop; 2005 Jun; 28(110):41-4. PubMed ID: 16245765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phosphomycin for the prevention of bacterial infections in high risk patients].
    Faedda R; Tocco A; Vacca R; Deplano A; Olmeo NA; Branca FG; Bartoli E
    Clin Ter; 1981 Nov; 99(3):295-304. PubMed ID: 7307457
    [No Abstract]   [Full Text] [Related]  

  • 39. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Mirakhur A; Gallagher MJ; Ledson MJ; Hart CA; Walshaw MJ
    J Cyst Fibros; 2003 Mar; 2(1):19-24. PubMed ID: 15463841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heresy? Treatment of chronic periodontitis with systemic antibiotics only.
    Mombelli A
    J Clin Periodontol; 2006 Sep; 33(9):661-2. PubMed ID: 16918990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.